TransEnterix is currently developing a patient-side robotic system called the SurgiBot™ System. The system is designed to be controlled directly by the surgeon, with enhanced vision and robotic motion. SurgiBot System design incorporates deployment of flexible instruments and a high-definition 3D articulating scope through a single incision.
The SurgiBot System is currently in development and has not yet been cleared by the FDA for sale in the United States or by other regulatory authorities for sale outside the United States.
August 06, 2015
TransEnterix, Inc. Reports Operating Results for the Second Quarter 2015
June 15, 2015
Triangle Business Journal: RTP’s TransEnterix raises $50M for commercial launch of surgery robot
June 01, 2015
TransEnterix Submits 510(k) Application to FDA for SurgiBot System
June 02, 2015
Triangle Business Journal: Research Triangle Park’s TransEnterix takes big step with surgical robot